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2Abstract
3-demensional (3D) culture model is a valuable in vitro tool to study liver biology, metabolism,
organogenesis, tissue morphology, drug discovery and cell-based assays. Compelling evidence
suggests that cells cultured in 3D model exhibit superior liver-specific functions over the
conventional 2-dimentional (2D) culture in evaluating hepatobiliary drug disposition and
drug-induced hepatotoxicity due to the in vivo-like physiological condition recapitulated by 3D
model technologies. We will review the attributes of 3D culture model in acquiring relevant liver
phenotypes and functionalities, discuss the critical niche factors found to modulate hepatocytes and
highlight recent advancements on 3D cell culture technologies to achieve next-level in vitro tool for
preclinical study. (Electronic word count of the abstract: 105)
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1. Introduction
The 3D cell culture is defined as an artificial environment allowing cells to grow and interact in all
three spatial dimensions, mimicking the in vivo architecture of liver that comprises of extracellular
matrix and nonparenchymal cells [1]. Due to the historical inertia in biotechnology, 2-dimensional
(2D) cell culture that relying on cells attaching to surface forming mono layer of confluent cell sheet
has instead been widely applied and in fact the predominant liver culture models in preclinical liver
studies. However, 2D cell culture model has failed to provide necessary niche factors thus far in
sustaining critical cellular phenotype due to the lack of proper intercellular connection in 3D thus
generating suboptimal pre-clinical results. For instance, many liver-specific gene expressions and
functions of primary human hepatocytes, such as albumin secretion, viral infectivity, and cytochrome
3P450 (CYP) enzyme activity [2, 3] are found to be rapidly deteriorating in 2D cell culture upon
seeding. These limitations spurred the scientists to explore better culture models. As early as 1912,
the 3D culture was first described [4] and opened up an avenue to address the limitation presented in
2D models. In association with the development of biomaterials and biotechnology, many 3D
systems with wide range of attributes and features have been proposed for regenerative medicine
(showed in Table 1).
In healthy condition, rat liver that has undergone surgical removal of up to 70% of liver mass –
referred to as partial hepatectomy – restores tissue mass and functions in just a week driven by
compensatory proliferation and hyperplasia. While In human, live donor recovery data show that
liver mass recovery takes about one year [5]. Unfortunately, this incredible endogenous regenerative
capability of liver could be threatened by a series of constant liver assaults including fibrosis and
cirrhosis caused by hepatitis infection, drug over dosing, ARLD, NASH, NAFLD, etc [6]. The loss
of liver functions could poise detrimental effects on patients because liver plays an important role in
a variety of critical functions, including the detoxification of the systemic and portal blood, secretion
multiple proteins and bile components [7]. Liver is the main organ in determining the
pharmacokinetics of any oral administrated drugs. Most of the drugs that have been withdrawn from
the clinical trials along the discovery pipeline or even from the market are partially caused by the use
of 2D culture in assessing the dose-dependent efficacy and predict the cytotoxicity of the drug in
vitro. For instance, acetaminophen (APAP), the most common household drug for pain killing, is the
leading cause for acute liver injury in the West due to overdosing [8]. Some researchers used
transcriptome profiling to reveal the mechanisms underlying the high-dose APAP induced
mitochondrial dysfunction in the 2D cultured HepG2 model [9]. The lack of expression of this
4enzyme could explain the insensitivity to APAP in the 2D cultures [10].The failure in drug
development is also partially attributed to poor correlation in the use animal models such as rodent,
porcine or non-human primate due to the cross-species physiological variation [11-13].
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths [14, 15] and
some researchers believe that high mortality is related to the current limitation of in vitro studies
which fail to mimic the human disease microenvironment [16].
This article will first introduce the attributes and niche factors associated with the 3D liver culture
system, then focus on some relevant advanced 3D systems and their respective applications.
2. Attributes of 3D liver cell culture
The principal goal of developing novel 3D liver culture model is to acquire relevant liver
phenotypes and functionalities in vitro. To achieve that, attributes such as microenvironmental
architecture, phenotypical sustainability and authentic functionality of the liver must be evaluated in
the development of new 3D culture model.
2.1 Microenvironmental architecture：Various 3D models have been proposed to recapitulate the
microenvironments of liver tissue in vitro in order to achieve authentic cell-cell interactions and cell
polarity that are essential for hepatic phenotypes [17-20]. The nature of the interaction with its
microenvironment dictates overall shape and cytoarchitecture of hepatocyte which, in turn, are
related to the expression of transcription factors and gene programs. For instance, the most widely
known model is called sandwich model where a monolayer of hepatocytes is sandwich top-to-bottom
by two layers of ECM protein such as collagen I or Matrigel [21]. This model provides minimal
cellular interaction needed for hepatocytes to establish hepatic polarity hence enabling bile salt
transportation [22]. 3D hydrogel cell encapsulated model is another model heavily employed to
5facilitate extensive cell-cell and cell-matrix interaction in 3D [23]. Unlike the sandwich model, cell
encapsulation model allows higher degree of mobility for cells to navigate. However, the downside is
the cells are generally suffering from necrosis due to the suboptimal mass transportation properties in
such 3D hydrogel [24] (Figure 1). To circumvent such diffusivity limitation, a series of macroporous
3D scaffolding models such as salt-leaching scaffold, inverse colloidal crystal scaffold and nanofiber
scaffolds have been developed to deliver highly porous scaffolds that allow cells to move freely in
the 3D microenvironment without compromising their physical integrity.
2.2 Phenotypical sustainability：Albeit the incredible regenerative capability in body, hepatocytes
harvested from liver tissue dedifferentiate rapidly when culture on 2D model, thus limiting their
preclinical potential [25]. Co-culturing stromal cells with hepatocytes in a 3D model that enables
secreted matrix to be deposited and organized was found to prolong the hepatic functions over 20
days in culture [26]. On a step forward, a nondegradable PEGdA/RGD hydrogel system was further
functionally enhanced by incorporation of hepatocyte aggregates (pucks) as well as supportive
stromal cells, resulting in prolonged preservation of hepatic function for 50 days [27]. The longest
time for culture systems preserving advanced hepatic functions with primary human hepatocytes was
at least 5 months [28].
2.3 Authentic functionality ： The liver is the main organ for processing drug. The authentic
representation of drug metabolism is paramount in preclinical study in evaluating the efficacy and
toxicity of the drug. Furthermore, the most potent, or toxic, form of a compound may not be the
primary compound but rather one of its metabolites [29]. Due to species-to-species variation in
metabolizing drug, a compound’s primary metabolite tested in animal study may vary drastically and
deem unhelpful in predicting hepatotoxicity in human [30]. Unfortunately, together with the
6aforementioned rapid deterioration of hepatic functions in vitro, such as the expression of critical
cytochrome P450 (CYP) drug metabolizing enzymes, the current mandatory preclinical studies are
insufficient to provide an accurate depiction on drug efficacy and safety. The hepatoma cell lines
have been proposed and widely used in the preclinical studies due to their superior expension
capability and relatively sustainable phenotypes. However, hepatoma cell lines are also known to
demonstrate signification variation in their performance and suboptimal functionality compared to
PHHs, particularly in detoxification, nitrogen, and carbohydrate metabolism [31]. One study showed
ammonia elimination is 64% the rate of elimination of PPH-BALs [32]. Multiple studies have
demonstrated the potential of 3D culture model in expressing the authentic metabolic activities
compared to the conventional the 2D model [26, 33].
3. Vital factors in the 3D cell culture system
3.1 Cellular interaction
Hepatocytes in liver organ rely on intricate interaction with its surroundings. Disruption on
specific parenchymal cell arrangement, interactions with nonparenchymal cells (NPC) and
extracellular matrix is known be the main cause of liver function deterioration observed in 2D model
[34, 35].
3.1.1 Homotypic cell interaction: Extensive cell–cell interactions is known to be influential to the
gene expression profiles and hence functionality [21, 36]. Studies reveal that hepatocytes cultured in
spheroids are more powerful than the 2D model in capturing the liver phenotypes and functions in
vitro due to extensive cell-cell interaction [10, 21, 24]. In addition, the diffusivity gradient of oxygen
and metabolic activity demonstrated by the hepatocytes position from the peripheral to the core of
7spheroids, when modulated accurately, could be used to model the metabolic zonation in vivo thus
making it a more relevant platform to study metabolic response in vitro. On the other hand, the
diameter of the spheroid is the most important variable to modulate in order to achieve consistent
readout. The configuration is direct contrast to spheroid/cell condensation culture systems where
cells at the periphery are more viable and proliferative than cells at the core due to hypoxia and DNA
damage [10, 37]. Hussein’s research showed the average diameter of the spheroids <180±12μm was
sufficient for oxygen diffusion as spheroids above 200μm were reported to become hypoxic in the
center [38].
3.1.2 Extracellular matrix construction: ECM, that comprises of a mosaic of lipids, proteins and
carbohydrates in a complex, heterogeneous and dynamic environment, plays an important role in
maintaining the differentiated phenotype of hepatocytes and NPCs [21, 39]. Collagen is the major
component of the ECM and it has been widely utilized to culture cells because of its excellent
characteristics, including biocompatibility, mechanical strength, degradability and limited
immunogenicity [40] and the most common used in 3D model. Matrigel consisting of natural
biopolymers: laminin, collagen IV and entactin, as well as various growth factors, has already
commercialized [34, 41]. Some researchers indicated that limited matrix formation enhanced hepatic
functionality of hepatocytes cultured in vitro [26] and the hepatic differentiation favored a relatively
low-density ECM compared with a densely packed ECM surface [42, 43].
3.1.3 Nonparenchymal cell: Even though NPCs account for only 20% of the liver mass, they play
critical roles in the construction and maintenance of extracellular matrix, as well as mediating
cellular function, including transport and metabolism [44]. Major liver NPCs include bile duct
epithelial cells, liver sinusoidal endothelial cells (LSEC), hepatic stellate cells (HSC) and Kupffer
8cells (KC).
LSECs play important roles in maintaining overall hepatic homeostasis and clearance,
bioactivation of drugs and other xenobiotics, and they are the target for some types of
chemical-induced hepatotoxicities [44]. The LSEC-specific phase 1 enzymes have been less well
characterized compared to their epithelial counterparts, but it is clear that they contribute to the
metabolism, clearance and bioactivation of endogenous and exogenous substrates [18]. It was
revealed that co-culture of primary hepatocyte with LSEC resulted to increase in hepatocyte
proliferation [45].
Under normal physiological conditions, HSC are morphologically characterized by their extensive
dendrite-like extensions, essentially “embracing” the endothelial cells [46]. This close contact
between HSC and their neighboring cells facilitates intercellular communication by the means of
soluble mediators and cytokines. HSC can be identified by desmin expression, a typical intermediate
filament protein within contractile cells. Mature HSC produce both network and fibrillar collagens
(large amounts of type I collagen and lower levels of type III, IV and V collagen), large amounts of
elastin and both heparan sulfate proteoglycans (HS-PG) and chondroitin. HSC also produce
important cytokines and growth factors for intercellular communication in normal and injured liver
[46].
Susceptibility to drugs is different in the healthy liver and in active inflammatory states [47].
Kupffer cells (KC), a type of stellate macrophage reside in the liver, are often targeted as the
candidate to study the drug metabolic reaction under inflammation. They play a vital role in immune
surveillance of the host and are involved in modulating systemic responses to severe infections and
controlling concomitant immune responses via antigen presentation and suppression of the activation
9and proliferation of T cells [48]. The PHH and KC co-culture models have been developed recently
to enable the evaluation of hepatocyte reactions in a pro-inflammatory environment [49, 50]. Notably,
this co-culture has demonstrated that inflammation is one of the factors that may increase the
sensitivity of hepatic cells to acetaminophen (APAP) induced toxicity [47].
KC is thought the immune cells in generally, but they also play a role in regeneration. In mouse
models of acute liver injury, KCs sense injury and become activated, leading to the release of
cytokines and chemokines, then the number of macrophages in the liver greatly expands in response
to tissue injury, mainly caused by attracting monocytes from the circulation. Although inflammatory
may aggravate injury but hepatic macrophages can become the main source of cytokines with
anti-inflammatory functions, such as IL-10, IL-4, and IL-13 and cooperate in tissue repair [51]. In
mouse models of chronic liver injury, macrophage engulfment of hepatocyte debris induces
expression of Wnt3a, which promotes the differentiation of hepatic progenitor cells towards
functional hepatocytes favoring parenchymal regeneration [52].
3.2 Scaffold construction
Liver is made of a repeated fundamental unit called lobule, in polygonal shape in hexagonal
arrangement. Portal triads consisting of the hepatic artery, bile duct, and portal vein are at the corners
of the lobule, while the central vein is in the central of the lobule. Plates of parenchymal cells or
hepatocytes radiate from the central vein to the perimeter of the lobule, which serves as a microcosm
of the major hepatic microenvironments, containing the essential cellular and physiological features
that define the unique architecture of the liver tissue. Hepatic plates or cords are generally one
hepatocyte thick and are separated from one another by the hepatic sinusoids which are lined by
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Liver sinusoidal endothelial cells [53, 54]. LSEC plasma membrane is characterized by small pores,
or fenestrations, 50–200 nm in diameter that can allow free diffusion of many substances [55]. HSC,
reside in the space of Disse-the perisinusoidal space between the basolateral surface of hepatocytes
and the anti-luminal side of sinusoidal endothelial cells [56]. KCs are localized within the sinusoidal
microvasculature on the luminal side of endothelial cells, however, they have long cytoplasmic
extensions that facilitate direct cell-to-cell contact with hepatocytes [57](Figure2).
With the development of various biotechnology and biomaterials, the constructions of new 3D
models come out constantly. The material chosen firstly must be biocompatible with cell growth, and
have great performance in chemical and physic stability such as radiation resistance, high
reproducibility, less batch-to-batch differences, and good mass transfer capability [58, 59].
Chitosan-gelatin (CG) porous structures, inverted colloidal crystal (ICC) structure, PEGdA/HA, 3D
bio-printing all use good biomaterials (some models show in Figure 3), and use some methods to
produce a porous structure with an excellent surface area to volume ratio facilitating infiltration and
communication.
3.2.1 Decellulerized matrix scaffold: Natural, non-artificial materials are the closest to the
environment in which cells grow. De Kock created decellularized rat livers to evaluate anticancer
drugs efficacy [60], which may be the first research exploring the possibility of using a rat liver
scaffold to generate 3D model to evaluate anticancer drugs efficacy. Kamal H followed the idea of
the De Kock and succeeded in generating decellularized whole rat liver scaffolds that maintained
vascular structure and ECM integrity via efficiently removing the cellular and nuclear materials.
Next, perfusion of the scaffold with target cells is via the portal vein and the cells were distributed
within the scaffold. Successfully, the cells retained their proliferation ability and were functional.
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Decellularized rat livers, derived from natural organ, are the ideal structural component of the cell
microenvironment which is composed of a sophisticated assembly of collagens, proteoglycans,
laminins, elastin, and growth factors. These components represent the basic substances needed for
cell growth attachment, growth, and proliferation [38]. The material of natural origin is the closest to
the creature, but availability of donor is the challenge.
3.2.2 Channel-liked scaffolds: Natural biomaterials such as decellularized liver as scaffold possess
perfect innate advantage in providing the right ligands and mircro-environmental cues for cells.
However, in additional to limiting sourcing, they known to vary batch to batch hence reproducibility
is always an issue for consistent biological readouts and manufacturing. In addition, natural
biomaterials are lacking the tunability that is critical for us to manipulate the physical, chemical and
biological aspects for highly specialized application. Synthetic biomaterials have thus been proposed
to overcome such disadvantages. Polyvinylidene fluoride (PVDF) hollow fibers with massive
micropores were used as scaffolds, providing sufficient space and protection for cell growth, meeting
the demand of exchanging materials between the inner cells and the outside media. Mixed with
collagen solutions, polyvinylidene fluoride (PVDF) hollow fibers will have a rough inner surface to
favor adherence, growth, proliferation and functional expressions of the cells. They have two major
functions: to gather cells and improve the long-term bioactivity and integrity of the cells. Then
cylindroids were formed within the hollow fibers with better adhesion, after cell suspensions and
being injected into the hollow fibers [58]. One study showed among the hepatocyte organoids,
cylindroids showed better performances over liver-specific functions than spheroids [61].
3.2.3 Macroporous scaffolds: Chitosan-gelatin (CG) porous structures were formed by
freeze-drying to develop 3D tissues [62]. CG porous structures, one could blend heparan sulfate to
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chitosan and gelatin and form porous structures to mimic the liver architecture. CG scaffolds have a
suitable pore size for infiltration of cells, suitable liver stiffness in hydrated conditions, conducive for
adhesion of various cell types [63], good degradation characteristics and scaffolds support matrix
synthesis by fibroblasts while minimizing proliferation Morphological changes in HepaRG cells and
their migration were observed in 2D cultures over an 8 day culture timeline while in the 3D system
were not[64].
Recently, the more advanced system about 3D cell culture is inverted colloidal crystal (ICC)
structure. It is also using artificial materials to build the model, but taking into account the anatomy
of the liver-3D hexagonally arrayed liver lobules, the functional units of human liver that collectively
make up the human liver organ. The internal geometry of the ICC then enables spontaneous
formation of heterotypic liver spheroid-like formation within each cavity and interconnected cell
growth across adjacent cavities in 3D hexagonally. Some researches indicated that primary human
liver fetal cell mixtures were seeded in it and preserved advanced hepatic functions during extended
culture time (at least 5 months) [18, 19]. Importantly, this engineered human liver tissue provided
proof-of-concept determination of human-specific drug metabolism, remained the ability to support
infection with human hepatitis virus for subsequent antiviral drug testing, and facilitated detection of
human-specific drug hepatotoxicity associated with late-onset liver failure [65]. ICC scaffolds is with
higher degrees of freedom than 2D cultures and other 3D cultures (e.g., bulk hydrogels) [20]. Even if
there is no co-cultured cell, free from Matrigel, MSCs, and human umbilical vein endothelial cells
(HUVECs), just using a 3D synthetic hydrogel scaffold made by compliant material (PEG) , the ICC
is better than 2D, whether in cell phenotype or functional restore [37]. The experimental results show
a good application prospect, but as the culture time prolongs, the function and phenotype of the liver
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will decrease and did not provide hepatocytes with defined stiffness of the 3D parenchymal liver
microenvironment.
3.2.4 Microporous scaffolds: In vivo, the microenvironment is dynamic balance rather than static.
The ECM is also influenced by cells, whether it is a parenchymal or non-parenchymal cell. None of
the previous models explored the effects of mechanical factors on hepatocytes. To indicate it, the
model that can change stiffness has been proposed. Fine-tuning of initial PEGdA/HA concentration
and maintenance of stiffness close to normal liver parenchymal part would provide hepatocytes with
prolonged functionally favorable microenvironments. Rapid degradation of HA-enriched zone in
semi-IPNs by enzymatic activity and ECM formation by supporting cells leads to stiffness change.
High-molecular-weight (1.5 MDa) HA formed defects in hydrogel networks during polymerization.
After being degraded, HA-enriched zone provided a space for initial cell to spread and network
forms. With the time going, the stiffness is always changing. The outcome when the elastic modulus
of the 3D liver model converges close to that of the in vivo liver (≈2.3 to 5.9 kPa), both phenotypic
and functional maturation of the 3D liver were realized [26]. Although these approaches were
successful in the improvement of 3D hepatic cultures, biomechanical alterations and consequent
functional changes in hepatic cells in the dynamic 3D microenvironment and tissue remodeling
during long-term culture, are currently not well described.
3.2.5 3D bio-printing: 3D bio-printing has its fascinating advantages: convenience, precision, and is
favored by scientists in the engineering and regenerative medicine. Just providing the biocompatible
materials and cells, inputing the information about you need tissue into the system, then the machine
will print it out, even for tiny things [66]. Vascular-like tubes, artificial skin, cartilage, and a wide
range of tissue constructs also including stem cells are produced by various 3D printing technologies
14
[67]. As for liver tissue, some researchers use DLP-based 3D bioprinting system to develope a 3D
hydrogel-based triculture model that possesses the physiologically relevant cell combination and
microarchitecture. The DLP-based 3D bioprinting system allows to embed hiPSC-HPCs and the
supporting cells origin from both endothelial and mesenchymal in a 3D microscale hexagonal
hydrogel construct [68].
3.3 Vasculature formation
3.3.1 Blood vessel engineering: This static culture condition lacks the shear stress associates with
blood flow that is deemed to be a critical factor in determining cell fates [69, 70]. To address this
problem, microfluidic was introduced into the design of liver cell culture model either by
engineering “vascular-like” microfluidic structure pre-seeding or by promoting vasculature formation
driven by the intrinsic properties of the seeded cells.
3D printing technology has been a powerful tool to engineer vascular-like microfluidic system, it
allows us to fabricate device that mimics the liver anatomy like sinusoidal channels using artificial
barrier layer [71]. On top of printing biomaterials as physical barrier, microfluidic direct writer
(MFDW) enables the 3D printer to construct device using cell-laden hydrogel by using openings
permitting media exchange [72]. The microfluidic fulfills the needs for physiological shear stress
that is known to promote the primary liver cell’s metabolic activity [70]. It has been theorized that
the large increase in portal flow per unit of residual tissue mass may be among the earliest triggers of
regeneration [52]. The results point to fluid mechanical stress and activation of regeneration-related
genes in liver progenitor cells. Shear stress could upregulate regeneration-related immediate early
genes in liver progenitors in 3D ECM-like microenvironments [73]. Each cell has its own most
suitable shear force. The lower stress has no significant different from static culture and the higher
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shear stress in the flow had consequently detached the cells from the microcarriers, causing cell
death and adverse cell count [69]. To fully utilize the benefit of having dynamic flow system that
provide oxygen and nutrient to the hepatocytes, perfusion-incubator-liver-chip (PIC) has been
developed to provide a long-term culture systems without manual medium change by assuring a
tangential flow of the media over the spheroids culture. The essential attribute of PIC is that the
design of the device assures a tangential flow over the cell culture to remove the metabolites and
by-products from the proximity of the cells and refresh the cell environment [74].
3.3.2 Cell-driven vasculature formation in organoid: Besides the engineering approach
mentioned above, in vitro-generated organ buds is a promising approach toward regenerating
functional and vascularized organs. Takebe co-cultured human fetal liver cells (hFLCs) or
hepatocytes derived from iPSCs with HUVECs and mesenchymal stem cells (hMSCs) and seeded
these cells onto Matrigel. hMSCs served as the driving force to fold the co-culture from 2D sheet
into 3D liver bud mimicking the fetal liver development. In the process of liver bud formation,
HUVECs developed into premature vasculature networks in vitro. This result suggested that
scaffold-free and self-condensation approaches are superior for the induction of vascularization
[73, 75]. Although the presence of endothelial cells was dispensable for the generation of
condensates, the post-transplant outcomes were clearly disappointing in the absence of HUVECs
because no signs of functional vascularization were observed in vivo. As for hMSCs, they
initiated condensation to form 3D structure while the lack of MSCs in the coculture led to a failure
in condensate formation which was dependent upon soft substrate condition. In addition, the
competition between cell-hydrogel and cell-cell interactions might be involved in the mechanism
underlying the formation of cell condensates, especially in their initiation process [75]. By
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transplanting liver bud into mice, analyses of these implants may reveal the superiority of
immature hepatic cells or progenitors for liver engineering rather than terminally differentiated
mature hepatocytes. The authors also demonstrated the ability to scale up the production of liver
buds to serve as the potential high throughput platform for drug discovery [76].
3.4 Cell sourcing: Since the stability and maintenance of the differentiated state of liver cells
depends on both, the cell type used and the culture model (e.g. 2D cultures or complex 3D cultures),
the choice of culture model in association with a specific hepatic cell source is critical for the success
of individual hepatic in vitro studies.
Primary human hepatocytes (PHH) are regarded as the gold standard in vitro model to evaluate
hepatic metabolism [77]. Because they naturally in the liver, reflect the complete functionality of the
human organ and provide highly predictive results in toxicological in vitro research. Primary
hepatocytes are preferable for cell therapy or pharmacology applications since they have not been
altered by genetic mutations that lead to cancer and are the actual cell-type within the normal liver
that catalyze exogenous medications. However, inter-individual differences and cell alterations due
to the isolation procedure cause some variations in experimental results, which make the
standardization of models difficult. In addition, the scarce availability and difficult logistics of
primary human liver cells prevent a larger scale use of the cells. Primary hepatocytes are rarely
available and can lose metabolic activity over the long term [38].
The immortalized cell line overcomes the shortcomings of primary hepatocytes and is widely used
in drug metabolism and hepatotoxicity. The high expression of phase II genes makes the HepG2 cell
line useful to study drug metabolisms [78]. Similar to HepG2, Huh7 cells express Phase I and Phase
II xenobiotic drug metabolism genes, as well as hepatocyte-specific transcripts. However, alterations
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in the hepatocyte-specific functions limit the accuracy of results for humans because of
transformation [77]. HepG2 cell line expresses very low levels of phase I drug-metabolizing
enzymes such as cytochrome P450s [76] and the incomplete expression of surface junction proteins
restricts hepatitis C virus entry into HepG2 that limit the usage in hepatisis exploration[79]. Huh7
human hepatoma-derived cell line allows the HCV entry and replication. At the same time, the
disadvantage is that makes use of a non-differentiated cell line that does not recapitulate the cellular
conditions encountered by HCV in vivo [80]. HepaRG, is a terminally differentiated hepatic cell
derived from human hepatocellular carcinoma cell lines. Unlike HepG2 and Huh 7 lines, they
possess stable phenotype and functional capacity of Phase I and II xenobiotic metabolizing enzymes
and transporters over other hepatic cell lines. They could proliferate and then differentiate to
hepatocytes and biliary cells under the right culture conditions [7]. Regardless of its superiority over
other cancer cell lines, HepaRG is still suffering from subpar sensitivity in predicting drug
metabolism and safety [81].
Although the claims on the identification and profiling of human liver cells have remained
controversial, the conventional consensus on human fetal liver cells has always been set on two main
populations, human hepatic stem cells (hHpSCs) and hepatoblasts. hHpSCs are AFP negative and
known to be the precursors to hepatoblasts. HHpSCs have excellent proliferative capability, as
shown by clonogenic expansion for >150 population doublings with phenotypic stability, and are
pluripotent, with the ability to give rise directly to committed biliary progenitors and hepatoblasts,
and thence to hepatocytic and biliary lineages, as well as to other endodermal cell types.
Hepatoblasts are bipotent self-renewing cell type capable of differentiating into hepatocytes and
cholangiocytes. The evidence that they yield mature liver tissue after transplantation supports the
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notion that they are potentially an excellent cell source for establishing long-term culture systems
with advanced hepatic functions [34]. However, one big problem is that this cell source is hard to
come by and the ethical concern is too much of a huddle to get approval from regulatory board.
Stem cells are the focus in the field of regeneration, such as induced pluripotent stem cells (iPSCs)
from somatic cells by forced expression of the reprogramming factors Oct3/4 and Sox2 and human
embryonic stem cells (hESCs) derived from the inner cell mass of blastocysts. ESCs and iPSCs can
proliferate indefinitely without loss of potency and retain capacity for differentiation to various cells
[8]. Nevertheless hESC raised ethical concerns about the use of hESC in research [81]. iPSCs have
raised considerable excitement in the field of regeneration because this technology has the potential
to fulfill the autologous transplantation that does not rely on the donor and life-long
immunosuppression. Although various protocols in deriving hepatocytes using stem cell
differentiation have been established to date, the generated hepatocyte-like cells (HLC) are
characterized to be more of a fetal liver cells with immature phenotypes with reduced hepatic
functionality than the fully functional PHH that are the gold standard for clinical application. In
addition, due to the lack of standardized criteria and profiling assay, it is difficult to compare the
success of different approaches and identify promising modifications that may enhance hepatocyte
maturation [78]. All the existing protocol relies on the understanding of embryogenesis in guiding
the supplementation of growth factors on the tissue culture dish [80].The advance of novel
sequencing technology further fuel the development of differentiation protocol by identifying the
right cell profiles and niches to produce.
4. Future direction
3D model is the trend now and will still be the main focus of liver research and development in
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foreseeable future. Bioartificial liver (BAL) system providing a life-saving straw for end-stage liver
failure without liver transplant, is successful in supporting patient liver function, such as substance
metabolism, detoxification, and albumin synthesis [82]. Injectable hydrogels have been paid more
attention on cell therapy and tissue regeneration because of the applications in minimally invasive
surgical procedures with ease of handling and complete filling of defect area [83]. Furthermore,
organoids transplanted into the animal demonstrated rescue effect from acute liver failure and
restored the critical liver function.
5. Summary
Phenotypical sustainability, authentic functionality are the main advantages of the 3D cell culture,
which can provide great model for drug research and exploration of treatment. And more advanced
3D model come out with excellent characteristic, that brings positive significance to human
development.
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Table1. The biomaterials used in the 3D models.
Fig. 1. Conventional 3D model. (A) Cell encapsulation model: Cells and alginate solution mixture is
dispersed into salt bath using syringe for rapid polymerization to form microbeads. (B) Sandwich model:
A monolayer of hepatocytes is sandwiched by two layers of ECM protein such as collagen I or
Matrigel. (C) Salt-leaching hydrogel: Sacrificial salt porogens are intitally mixed with the hydrogel
for polymerization, then leached out to form macroporous hydrogel.
Fig. 2. The structure of the liver hepatic lobules. (A) The structure of the hepatic lobules and
interlobules. (B) The location of the variety of the cells in liver.
Fig. 3. Advanced 3D model. (A) Decellularized liver: The liver organ is decellularized and reseeded
using target cells for repopulation over the native matrix. (B) Inverted colloidal crystal (ICC):
Hydrogel with highly uniform pore size and porosity mimicking the 3D hexagonal structure of liver
31
lobule. (C) Channel-liked scaffolds: cell suspensions are injected into the hollow fibers to form
cylindroids.
